Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaRégis Peffault de Latour, Antonio M. Risitano, Fiorenza Barraco et al.|New England Journal of Medicine|2022Cited by 309
Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race TrialD Kaya, Ghulam Mufti, Riley Cook et al.|Blood|2024Cited by 2
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and EltrombopagDeniz Ece Kaya, Ghulam Mufti, Riley Cook et al.|NEJM Evidence|2026Cited by 2
Deep immune signature of immune-mediated aplastic anemia patients shows distinct subsets of regulatory T cells associated with response to treatment: Results from the phase 3, randomized EBMT race clinical trialSıla Gerlevik, Ghulam Mufti, Giorgio Napolitani et al.|Blood|2025Cited by 0